psoriasis and semaglutide therapy decreases epicardial fat inflammation improves severity in patients affected by abdominal obesity and type-2 diabetes – ScienceOpen Psoriasis, RA & GLP-1s: Weight-Loss

Comparison with SGLT2 inhibitors in metabolic regulation Both GLP-1 RAs and sodium-glucose cotransporter-2 inhibitors (SGLT2is) have demonstrated clinically meaningful improvements in metabolic parameters and liver health in patients with NASH

However, most of these are limited to bruising and bleeding at the injection site, headache, and dizziness

After 12 months on the programme, patients lost an average of 17% of their body weight, while sick days fell by 30% and GP and hospital appointments fell by 42%

While heartburn can be bothersome, it is typically manageable through dietary modifications, lifestyle adjustments, and when necessary, acid-suppressing medications

Shiraishi and colleagues demonstrated upregulation of alternatively activated macrophage-related molecules, such as IL-10, CD163, and CD204 in human monocyte-derived macrophage by GLP-1 [95]